These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24821613)

  • 21. Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing?
    Harry O; Crosby LE; Smith AW; Favier L; Aljaberi N; Ting TV; Huggins JL; Modi AC
    Lupus; 2019 Apr; 28(5):642-650. PubMed ID: 30907294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric Evaluation of the National Institutes of Health Patient-Reported Outcomes Measurement Information System in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort.
    Katz P; Yazdany J; Trupin L; Rush S; Helmick CG; Murphy LB; Lanata C; Criswell LA; Dall'Era M
    Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1630-1639. PubMed ID: 30354017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
    Ferreira JC; Marques HH; Ferriani MP; Gormezano NW; Terreri MT; Pereira RM; Magalhães CS; Campos LM; Bugni V; Okuda EM; Marini R; Pileggi GS; Barbosa CM; Bonfá E; Silva CA
    Lupus; 2016 Jun; 25(7):754-9. PubMed ID: 26821966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE).
    Kohut SA; Williams TS; Jayanthikumar J; Landolt-Marticorena C; Lefebvre A; Silverman E; Levy DM
    Lupus; 2013 Jun; 22(7):712-20. PubMed ID: 23704369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort.
    Son MB; Sergeyenko Y; Guan H; Costenbader KH
    Lupus; 2016 Nov; 25(13):1431-1439. PubMed ID: 27013665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study.
    Oliveira S; Ravelli A; Pistorio A; Castell E; Malattia C; Prieur AM; Saad-Magalhães C; Murray KJ; Bae SC; Joos R; Foeldvari I; Duarte-Salazar C; Wulffraat N; Lahdenne P; Dolezalova P; de Inocencio J; Kanakoudi-Tsakalidou F; Hofer M; Nikishina I; Ozdogan H; Hashkes PJ; Landgraf JM; Martini A; Ruperto N;
    Arthritis Rheum; 2007 Feb; 57(1):35-43. PubMed ID: 17266064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort.
    Peschken CA; Katz SJ; Silverman E; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga HO; Gladman DD; Urowitz M; Zummer M; Clarke A; Bernatsky S; Hudson M;
    J Rheumatol; 2009 Jun; 36(6):1200-8. PubMed ID: 19369456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early versus later onset childhood-onset systemic lupus erythematosus: Clinical features, treatment and outcome.
    Hui-Yuen JS; Imundo LF; Avitabile C; Kahn PJ; Eichenfield AH; Levy DM
    Lupus; 2011 Aug; 20(9):952-9. PubMed ID: 21676918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Aerobic Capacity and Quality of Life in Physically Inactive Patients With Systemic Lupus Erythematosus With Mild or Inactive Disease.
    Pinto AJ; Miyake CN; Benatti FB; Silva CA; Sallum AM; Borba E; de Sá-Pinto AL; Bonfá E; Gualano B
    Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1780-1786. PubMed ID: 27058995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of systemic lupus erythematosus in Oman: from childhood to adulthood.
    Al Rasbi A; Abdalla E; Sultan R; Abdullah N; Al Kaabi J; Al-Zakwani I; Abdwani R
    Rheumatol Int; 2018 Sep; 38(9):1691-1698. PubMed ID: 29721697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls.
    Schonenberg-Meinema D; Bergkamp SC; Nassar-Sheikh Rashid A; van der Aa LB; de Bree GJ; Ten Cate R; Cutolo M; Hak AE; Hissink Muller PC; van Onna M; Kuijpers TW; Smith V; van den Berg JM
    Lupus; 2021 Apr; 30(5):818-827. PubMed ID: 33657918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus.
    Sinicato NA; Postal M; de Oliveira Peliçari K; Rittner L; Marini R; Appenzeller S
    Clin Rheumatol; 2017 Jul; 36(7):1527-1535. PubMed ID: 28424906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis.
    Williams TS; Aranow C; Ross GS; Barsdorf A; Imundo LF; Eichenfield AH; Kahn PJ; Diamond B; Levy DM
    Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1178-87. PubMed ID: 21560254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus.
    Cintrón D; Alanis JM; Álvarez-Villalobos N; Rodríguez-Gutiérrez R; Vilá LM
    Lupus; 2020 Mar; 29(3):303-310. PubMed ID: 32031032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus.
    Tanigava NY; Sakamoto AP; Franco AS; Balbi GG; Sales LP; Aikawa NE; Terreri MT; Pereira RM
    Lupus; 2022 Jul; 31(8):944-952. PubMed ID: 35467441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry.
    AlAhmed O; Sivaraman V; Moore-Clingenpeel M; Ardoin SP; Bout-Tabaku S;
    Lupus; 2020 Dec; 29(14):1926-1936. PubMed ID: 33016198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S; Adrovic A; Barut K; Durmus S; Gelisgen R; Uzun H; Kasapcopur O
    Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus.
    Heshin-Bekenstein M; Trupin L; Yelin E; von Scheven E; Yazdany J; Lawson EF
    Semin Arthritis Rheum; 2019 Oct; 49(2):267-272. PubMed ID: 31235075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus.
    Mann CM; Schanberg LE; Wang M; von Scheven E; Lucas N; Hernandez A; Ringold S; Reeve BB
    Qual Life Res; 2020 Sep; 29(9):2573-2584. PubMed ID: 32410143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.